Share-based Payment Arrangement, Expense of GUIDED THERAPEUTICS INC from 30 Jun 2011 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
GUIDED THERAPEUTICS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2011 to 31 Mar 2024.
  • GUIDED THERAPEUTICS INC Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $14,837, a 86% decline year-over-year.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2023 was $235,980, a 34% increase from 2022.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2022 was $175,647, a 23% decline from 2021.
  • GUIDED THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2021 was $228,000, a 26% decline from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $14,837 -$92,231 -86% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $107,068 +$63,068 +143% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $44,000 -$18,000 -29% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q1 2021 $62,000 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2014 $298,000 -$132,000 -31% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q3 2013 $130,000 -$13,000 -9.1% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q1 2013 $430,000 +$232,000 +117% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q3 2012 $143,000 +$47,000 +49% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $152,000 +$43,000 +39% 01 Apr 2012 30 Jun 2012 10-Q/A 24 Aug 2012 2012 Q2
Q1 2012 $198,000 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q3 2011 $96,000 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3
Q2 2011 $109,000 01 Apr 2011 30 Jun 2011 10-Q/A 24 Aug 2012 2012 Q2

GUIDED THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $235,980 +$60,333 +34% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $175,647 -$52,353 -23% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $228,000 -$82,000 -26% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2022 2021 FY
2020 $310,000 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.